263 related articles for article (PubMed ID: 9248660)
1. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
Debyser Z; Reynders M; Goubau P; Desmyter J
Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
[TBL] [Abstract][Full Text] [Related]
2. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections.
Schubert J; Zens W; Weissbrich B
J Clin Virol; 1998 Dec; 11(3):161-72. PubMed ID: 9949952
[TBL] [Abstract][Full Text] [Related]
4. Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion.
Hinderer W; Lang D; Rothe M; Vornhagen R; Sonneborn HH; Wolf H
J Clin Microbiol; 1999 Oct; 37(10):3239-44. PubMed ID: 10488185
[TBL] [Abstract][Full Text] [Related]
5. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR.
Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR
Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.
de Ory F; Guisasola ME; Sanz JC; García-Bermejo I
Clin Vaccine Immunol; 2011 Mar; 18(3):444-8. PubMed ID: 21191077
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
Appak O; Ozkaratas MH; Sayiner AA
J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
Corrales I; Giménez E; Navarro D
Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.
Tranchand-Bunel D; Gras-Masse H; Bourez B; Dedecker L; Auriault C
J Clin Microbiol; 1999 Jul; 37(7):2366-8. PubMed ID: 10364618
[TBL] [Abstract][Full Text] [Related]
10. Serodiagnosis of infectious mononucleosis in children.
Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
Acta Paediatr Jpn; 1998 Aug; 40(4):328-32. PubMed ID: 9745774
[TBL] [Abstract][Full Text] [Related]
11. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation.
Gray JJ
J Virol Methods; 1995 Mar; 52(1-2):95-104. PubMed ID: 7769043
[TBL] [Abstract][Full Text] [Related]
12. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
[TBL] [Abstract][Full Text] [Related]
13. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
[TBL] [Abstract][Full Text] [Related]
14. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
Obel N; Høier-Madsen M; Kangro H
APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
[TBL] [Abstract][Full Text] [Related]
15. A systematic study of Epstein-Barr virus serologic assays following acute infection.
Rea TD; Ashley RL; Russo JE; Buchwald DS
Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.
Gärtner BC; Hess RD; Bandt D; Kruse A; Rethwilm A; Roemer K; Mueller-Lantzsch N
Clin Diagn Lab Immunol; 2003 Jan; 10(1):78-82. PubMed ID: 12522043
[TBL] [Abstract][Full Text] [Related]
17. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
[TBL] [Abstract][Full Text] [Related]
19. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.
Schaade L; Kleines M; Häusler M
J Clin Microbiol; 2001 Nov; 39(11):3902-5. PubMed ID: 11682505
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
